Intestinal first-pass metabolism of CYP3A4 substrates.

@article{Kato2008IntestinalFM,
  title={Intestinal first-pass metabolism of CYP3A4 substrates.},
  author={Motohiro Kato},
  journal={Drug metabolism and pharmacokinetics},
  year={2008},
  volume={23 2},
  pages={
          87-94
        }
}
Cytochrome P450 3A4 (CYP3A4) is present not only in the liver but also in the small intestine, where it functions as a barrier against xenobiotics. Some CYP3A4 substrates exhibit low bioavailability due to intestinal first pass metabolism. The AUCs of such CYP3A4 substrates are remarkably changed by the inhibition, induction, and saturation of CYP3A4 and so prediction of intestinal first-pass metabolism is important. In this article, factors affecting intestinal first-pass metabolism of drugs… CONTINUE READING

Figures, Tables, and Topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.
SHOWING 1-10 OF 30 CITATIONS

Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.

  • Drug metabolism and disposition: the biological fate of chemicals
  • 2015
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 75 REFERENCES

The human intestinal cytochrome P450 "pie".

  • Drug metabolism and disposition: the biological fate of chemicals
  • 2006

Similar Papers

Loading similar papers…